Find Diabetic Retinopathy Clinical Trials Near You
Multicenter National Parallel Cluster Randomized Controlled Superiority Trial Comparing an Artificial Intelligence-Based Screening Strategy to Usual Care for Improving Eye-Care Follow-Up Among Patients With Diabetes (AI-BRIDGE Trial)
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This pragmatic clinical trial is being conducted to test the effectiveness of AI-BRIDGE (Artificial Intelligence-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education), in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 8 primary care clinics. AI-BRIDGE is an implementation program which includes an autonomous AI-based protocol that provides screening for diabetic retinopathy (DR) disease at primary care visits, as well as patient education on disease and, if a patient screens positive for referable DR or has insufficient quality image, or image unobtainable due to other technical issues, or does not get AI-screening for any reason, assistance with scheduling an in-person, follow-up eye-care visit.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Healthy Volunteers: f
View:
• Clinic must be from a health system with at least two clinics that meet eligibility criteria and will agree to join.
• Number of unique patients with diabetes should be \>550 over any continuous 15-month period prior to the clinic providing a letter of support to participate in the trial.
• No point-of-care screening system in use for DR.
• Have an electronic health record to track patient data and agree to share limited data set as requested.
• Have a member of the clinical team who can commit to serving as the clinic champion for this study.
• Have the IT infrastructure to deploy an artificial-intelligence-based eye camera in the clinic.
• Diagnosis of type 1 or 2 diabetes
• No known diabetic retinopathy
• No diabetic retinopathy screening in the past 12 months
Locations
United States
Wisconsin
UW School of Medicine and Public Health
RECRUITING
Madison
Contact Information
Primary
Mozhdeh Bahrainian
bahrainian@wisc.edu
608-262-9955
Backup
Roomasa Channa
rchanna@wisc.edu
Time Frame
Start Date:2026-10-01
Estimated Completion Date:2030-05
Participants
Target number of participants:6900
Treatments
Active_comparator: Health System 1: Usual Care plus Education
4 month period of usual care screening then randomized to a 15-month period of usual care. Participants in usual care will receive educational material about diabetic retinopathy.
Experimental: Health System 1: AI-BRIDGE Clinic
4 month period of usual care screening then randomized to a 15-month period of AI-based eye screening program called AI-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education (AI-BRIDGE).
Active_comparator: Health System 2: Usual Care plus Education
4 month period of usual care screening then randomized to a 15-month period of usual care. Participants in usual care will receive educational material about diabetic retinopathy.
Experimental: Health System 2: AI-BRIDGE Clinic
4 month period of usual care screening then randomized to a 15-month period of AI-based eye screening program called AI-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education (AI-BRIDGE).
Active_comparator: Health System 3: Usual Care plus Education
4 month period of usual care screening then randomized to a 15-month period of usual care. Participants in usual care will receive educational material about diabetic retinopathy.
Experimental: Health System 3: AI-BRIDGE Clinic
4 month period of usual care screening then randomized to a 15-month period of AI-based eye screening program called AI-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education (AI-BRIDGE).
Active_comparator: Health System 4: Usual Care plus Education
4 month period of usual care screening then randomized to a 15-month period of usual care. Participants in usual care will receive educational material about diabetic retinopathy.
Experimental: Health System 4: AI-BRIDGE Clinic
4 month period of usual care screening then randomized to a 15-month period of AI-based eye screening program called AI-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education (AI-BRIDGE).